Literature DB >> 7033328

A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics.

M J Brown, P W Ind, R Causon, T H Lee.   

Abstract

The concentration of plasma histamine may provide an index of mast cell activation (degranulation) and can be measured by a sensitive radioenzymatic assay based on its specific conversion to (3H)-methylhistamine in the presence of histamine-N-methyltransferase and (3H)-S-adenosyl-L-methionine. In this assay, the separation of excess (3H)-S-adenosyl-L-methionine from (3H)-methylhistamine requires several steps, for which a correction factors is necessary to maintain precision. In the present modification, duplicate 50-microliters aliquots of each plasma sample were incubated with histamine-N-methyltransferase and (3H)-S-adenosyl-L-methionine. A further aliquot, with an added standard of 200 ng/ml histamine, was incubated with histamine-N-methyl-transferase and (14C)-S-adenosyl-L-methionine. This standard was converted to (14C)-methylhistamine, and its recovery at the end of the assay corrected both for varying efficiency of methylation among plasma samples and for losses during the subsequent extraction and separation stages. The sensitivity of the assay was 25 pg/ml. The intra-assay and interassay coefficients of variation were 7.2% and 11.6%, respectively. In five asthmatics, antigen challenge caused a 28% fall in FEV1, and this was associated with a twofold to threefold rise in plasma histamine concentration. This assay may thus prove a useful method for assessing the role of mast cell release of mediators in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7033328     DOI: 10.1016/0091-6749(82)90082-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  22 in total

1.  Tear histamine during allergic conjunctivitis challenge.

Authors:  O Kari; O P Salo; L Halmepuro; K Suvilehto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

2.  Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.

Authors:  J Tseng; J L Komisar; R N Trout; R E Hunt; J Y Chen; A J Johnson; L Pitt; D L Ruble
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

3.  Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex.

Authors:  P J Barnes; M J Brown; C T Dollery; R W Fuller; D J Heavey; P W Ind
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

4.  Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

Authors:  E N Charlesworth; A F Hood; N A Soter; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Authors:  L B Schwartz; J W Yunginger; J Miller; R Bokhari; D Dull
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

6.  De novo generation of histamine in sputum and the effect of antibiotics.

Authors:  B D Sheinman; J L Devalia; S J Crook; R J Davies
Journal:  Agents Actions       Date:  1986-03

Review 7.  Diagnostic role of serum tryptase in anaphylactic deaths in forensic medicine: a systematic review and meta-analysis.

Authors:  Kai-Jian Sun; Jie-Tao He; Hong-Yan Huang; Ye Xue; Xiao-Li Xie; Qi Wang
Journal:  Forensic Sci Med Pathol       Date:  2018-04-21       Impact factor: 2.007

8.  Histamine symptoms and histamine metabolism in chronic granulocytic leukaemia.

Authors:  G Granerus; A Weinfeld; J Westin
Journal:  Agents Actions       Date:  1983-04

9.  Treatment of two mastocytosis patients with a histidine decarboxylase inhibitor.

Authors:  G Granerus; J H Olafsson; G Roupe
Journal:  Agents Actions       Date:  1985-04

10.  Histamine released locally after intradermal antigen challenge in man.

Authors:  D J Heavey; P W Ind; A Miyatake; M J Brown; J Macdermot; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.